NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 172 filers reported holding NOVAVAX INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $351,000 | +32.0% | 298,730 | +106.5% | 0.00% | – |
| Q4 2018 | $266,000 | -1.8% | 144,665 | +0.5% | 0.00% | – |
| Q3 2018 | $271,000 | +40.4% | 143,965 | 0.0% | 0.00% | – |
| Q2 2018 | $193,000 | -36.1% | 143,965 | 0.0% | 0.00% | – |
| Q1 2018 | $302,000 | +68.7% | 143,965 | 0.0% | 0.00% | – |
| Q4 2017 | $179,000 | – | 143,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |